Symptoms in patients with ulcerative colitis in remission are associated with visceral hypersensitivity and mast cell activity

References

• Longstreth GF, Thompson WG, Chey WD, Houghton LA, Mearin F, Spiller RC. Functional bowel disorders. Gastroenterology 2006;130:1480–91.
   PubMed Web of Science ®Google Scholar
• van der Veek PP, Van Rood YR, Masclee AA. Symptom severity but not psychopathology predicts visceral hypersensitivity in irritable bowel syndrome. Clin Gastroenterol Hepatol 2008;6:321–8.
   PubMed Web of Science ®Google Scholar
• Kanazawa M, Palsson OS, Thiwan SI, Turner MJ, van Tilburg MA, Gangarosa LM, Contributions of pain sensitivity and colonic motility to IBS symptom severity and predominant bowel habits. Am J Gastroenterol 2008;103:2550–61.
   PubMed Web of Science ®Google Scholar
• Apiroz F, Bouin M, Camilleri M, Mayer EA, Poitras P, Serra J, Mechanisms of hypersensitivity in IBS and functional disorders. Neurogastroenterol Motil 2007;19:62–88.
   PubMed Web of Science ®Google Scholar
• Barbara G, Stanghellini V, De Giorgio R, Cremon C, Cottrell GS, Santini D, Activated mast cells in proximity to colonic nerves correlate with abdominal pain in irritable bowel syndrome. Gastroenterology 2004;126:693–702.
   PubMed Web of Science ®Google Scholar
• Barbara G, Wang B, Stanghellini V, de Giorgio R, Cremon C, Di Nardo G, Mast cell-dependent excitation of visceral-nociceptive sensory neurons in irritable bowel syndrome. Gastroenterology 2007;132:26–37.
   PubMed Web of Science ®Google Scholar
• Dunlop SP, Jenkins D, Spiller RC. Distinctive clinical, psychological, and histological features of postinfective irritable bowel syndrome. Am J Gastroenterol 2003;98:1578–83.
   PubMed Web of Science ®Google Scholar
• Cremon C, Gargano L, Morselli-Labate AM, Santini D, Cogliandro RF, De Giorgio R, Mucosal immune activation in irritable bowel syndrome: gender-dependence and association with digestive symptoms. Am J Gastroenterol 2009;104:392–400.
   PubMed Web of Science ®Google Scholar
• Parry S, Forgacs I. Intestinal infection and irritable bowel syndrome. Eur J Gastroenterl & hep 2005;17:5–9.
   PubMed Web of Science ®Google Scholar
• Rodriguez LA, Ruigomez A. Increased risk of irritable bowel syndrome after bacterial gastroenteritis: cohort study. BMJ 1999;318:565–6.
   PubMed Web of Science ®Google Scholar
• Spiller RC. Postinfectious irritable bowel syndrome. Gastroenterology 2003;124:1662–71.
   PubMed Web of Science ®Google Scholar
• Podolsky DK. Inflammatory bowel disease. N Engl J Med 2002;347:417–29.
   PubMed Web of Science ®Google Scholar
• He SH. Key role of mast cells and their major secretory products in inflammatory bowel disease. World J Gastroenterol 2004;10:309–18.
   PubMed Web of Science ®Google Scholar
• Seo M, Okada M, Maeda K, Oh K. Correlation between endoscopic severity and the clinical activity index in ulcerative colitis. Am J Gastroenterol 1998;93:2124–9.
   PubMed Web of Science ®Google Scholar
• Chang L, Munakata J, Mayer EA, Schmulson MJ, Johnson TD, Bernstein CN, Perceptual responses in patients with inflammatory and functional bowel disease. Gut 2000;47:497–505.
   PubMed Web of Science ®Google Scholar
• Minderhoud IM, Oldenburg B, Wismeijer JA, van Berge Henegouwen GP, Smout AJ. IBS-like symptoms in patients with inflammatory bowel disease in remission; relationships with quality of life and coping behavior. Dig Dis Sci 2004;49:469–74.
   PubMed Web of Science ®Google Scholar
• Keohane J, O'Mahony C, O'Mahony L, O'Mahony S, Quigley EM, Shanahan F. Irritable bowel syndrome-type symptoms in patients with inflammatory bowel disease: a real association or reflection of occult inflammation ? Am J Gastroenterol 2010;105: 1788, 1789–94.
   Web of Science ®Google Scholar
• Schroeder KW, Tremaine WJ, Ilstrup DM. Coated oral 5-aminosalicylic acid therapy for mildly to moderately active ulcerative colitis. A randomized study. N Engl J Med 1987;317:1625–9.
   PubMed Web of Science ®Google Scholar
• van der Veek PP, Swenne CA, Vooren H, Schoneveld AL, Maestri R, Masclee AA. Viscerosensory-cardiovascular reflexes: altered baroreflex sensitivity in irritable bowel syndrome. Am J Physiol Regul Integr Comp Physiol 2005;289:R970–6.
   PubMed Web of Science ®Google Scholar
• Baron RM, & Kenny DA. The moderator-mediator variable distinction in social psychological research: Conceptual, strategic and statistical considerations. Journal of Personality and Social Psychology 1986;51:1173–82.
   PubMed Web of Science ®Google Scholar
• Isgar B, Harman M, Kayd M, Symptoms of irritable bowel syndrome in ulcerative colitis in remission. Gut 1983;24:190–2.
   PubMed Web of Science ®Google Scholar
• Simrén M, Axelsson J, Gillberg R, Quality of life in inflammatory bowel disease in remission> the impact of IBS-like symptoms and associated psychological factors. Am J Gastroenterol 2002:97:389–96.
   PubMed Web of Science ®Google Scholar
• Farrokhyar F, Marshall JK, Easterbrook B, Irvine EJ. Functional gastrointestinal disorders and mood disorders in patients with inactive inflammatory bowel disease: prevalence and impact on health. Inflamm Bowel Dis 2006;12:38–46.
   PubMed Web of Science ®Google Scholar
• Ansari R, Attari F, Razjouyan H. Ulcerative colitis and irritable bowel syndrome: relationships with quality of life. Eur J Gastroenterol Hepatol 2008;20:46–50.
   PubMed Web of Science ®Google Scholar
• La JH, Kim TW, Sung TS, Kim HJ, Kim JY, Yang IS. Role of mucosal mast cells in visceral hypersensitivity in a rat model of irritable bowel syndrome. J Vet Science (Suwon-si, Korea) 2004;5:319–24.
   Google Scholar
• Bueno L. Protease activated receptor 2: a new target for IBS treatment. European Rev Med Pharm Sci 2008;12 (Suppl 1):95–102.
   PubMed Web of Science ®Google Scholar
• Dabek M, Ferrier L, Roka R, Gecse K, Annahazi A, Moreau J, Luminal cathepsin g and protease-activated receptor 4: a duet involved in alterations of the colonic epithelial barrier in ulcerative colitis. Am J Path 2009;175:207–14.
   PubMed Web of Science ®Google Scholar
• Sharkey KA. Visceral sensation and colitis: inflammation and hypersensitivity do not always go hand in hand. Neurogastroenterol Motil 2006;18:87–90.
   PubMed Web of Science ®Google Scholar
• Bueno L, Fioramonti J, Delvaux M, Frexinos J. Mediators and pharmacology of visceral sensitivity: from basic to clinical investigations. Gastroenterology 1997;112:1714–43.
   PubMed Web of Science ®Google Scholar